849PD - Preliminary results of a phase I/II dose-escalation study of fractionated dose 177Lu-PSMA-617 for progressive metastatic castration resistant prostate cancer (mCRPC)

Autor: Tagawa, S.T., Osborne, J.R., Hackett, A., Niaz, M.J., Cooley, V., Christos, P., Vlachostergios, P.J., Thomas, C., Gracey, L., Beltran, H., Molina, A.M., Nanus, D.M., Babich, J., Vallabhajosula, S., Sartor, O., Ballman, K., Bander, N.H.
Zdroj: In Annals of Oncology October 2019 30 Supplement 5:v329-v330
Databáze: ScienceDirect